JENNA OATES: Open Payments
NPI 1013304468 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,756 in 137 payments from 48 companies in 2025. Trend: 2023 $2,586 · 2024 $2,434 · 2025 $2,756
Food & beverage: $2,756
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 10 | $201 |
| Incyte Corporation | 8 | $161 |
| Novartis Pharmaceuticals Corporation | 9 | $160 |
| E.R. Squibb & Sons, L.L.C. | 7 | $151 |
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| Janssen Biotech, Inc. | 6 | $113 |
| ABBVIE INC. | 4 | $104 |
| Lilly USA, LLC | 5 | $98 |
| GENZYME CORPORATION | 4 | $95 |
| PFIZER INC. | 7 | $89 |
Products named: OPDIVO, LIBTAYO, BRUKINSA, MONJUVI, Tecentriq, VERZENIO, ERLEADA, XTANDI.
Industry payments across AL — which companies pay providers there.
